HIV Clinical Trial
— PtWOfficial title:
Passport to Wellness-Full Intervention Phase
NCT number | NCT02932384 |
Other study ID # | TL13-LACA-576 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2015 |
Est. completion date | April 2018 |
Verified date | August 2018 |
Source | Charles Drew University of Medicine and Science |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The proposed research study will focus on Black men who have sex with men (BMSM) who
- are HIV- or unknown status AND
- have not received HIV testing in over a year or
- who test irregularly (on 9/21/2016, the protocol was changed to modify the last to
criteria and focus on those who have not used PrEP in the prior six months).
and implement an innovative, culturally-informed, peer-based, and client-centered approach
that is designed to increase their awareness of their HIV status and their timely entry into
prevention (including PrEP), testing, care, and treatment services. The research design
compares the effect of an incentives-only approach to one that uses incentives, along with
the involvement of peer mentors to support timely entry into prevention, testing, care and
treatment. This phase of the study is designed to assess peer-supported intervention group
versus a passport/incentive-only control group over an 18-month period using a randomized
trial approach.
Status | Completed |
Enrollment | 105 |
Est. completion date | April 2018 |
Est. primary completion date | April 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: 1. self identify as male 2. self-identify as Black or African American 3. sex with a male or male-to-female transgender in the last 6 months 4. intercourse without a condom in the last 6 months 5. Los Angeles County resident, 6. either is unaware of HIV status and has not tested for HIV in the last 12 months or has recently tested (within 30 days), but had not received testing in the prior 12 months - 6) Modified 9/21/2016 to has not taken PrEP in the prior 6 months Exclusion criteria: 1. self-identify as female or transgender male or female 2. does not self-identify as Black or African American 3. no sex with a man or a male-to-female transgender in the last 6 months 4. no sexual intercourse in the last 6 months 5. resides outside of Los Angeles County 6. is HIV-positive OR has tested between 1 and 13 months prior to enrollment. - 6) Modified 9/21/2016 to has not taken PrEP in the prior 6 months |
Country | Name | City | State |
---|---|---|---|
United States | Charles Drew University of Medicine and Science | Los Angeles | California |
United States | Los Angeles Centers for Alcohol and Drug Abuse (LA CADA) | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
Charles Drew University of Medicine and Science | Los Angeles Centers for Alcohol and Drug Addiction (L.A. CADA), University of California, Los Angeles, University of Southern California |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number self-reporting specific HIV/STD (sexually transmitted disease) Testing outcomes | --Number of participants 1) human immunodeficiency virus (HIV) tested within one and six months of their baseline; 2) newly diagnosed with HIV, and 3) obtaining testing for other STDs within six months of their baseline. | 6 Months | |
Primary | Number with specific PrEP outcomes | --Number of participants who attend a PrEP information session, meet with a PrEP provider, or obtain a new PrEP prescription. | 6 Months | |
Primary | Number self-reporting specific Social and Behavioral Outcomes | --Number of participants who obtain social and behavioral services that support HIV prevention and care. | 6 Months | |
Primary | Percentage self-reporting specific HIV/STD (sexually transmitted disease) Testing outcomes | --Percentage of participants 1) human immunodeficiency virus (HIV) tested within one and six months of their baseline; 2) newly diagnosed with HIV, and 3) obtaining testing for other STDs within six months of their baseline. Summary data may include the percentage who report HIV or STD testing. | 6 Months | |
Primary | Percentage with specific PrEP outcomes | --Percentage of participants who attend a PrEP information session, meet with a PrEP provider, or obtain a new PrEP prescription. Summary items may include the percentage who report doing any of these three PrEP activities. | 6 Months | |
Primary | Percentage of self-reporting specific Social and Behavioral Outcomes | --Percentage of participants who obtain social and behavioral services that support HIV prevention and care. | 6 Months | |
Secondary | Number of referrals HIV tested | The investigators will compare between the two arms, the number of HIV tested referrals from study participants in each arm who were 1) BMSM, 2) BMSM newly diagnosed with HIV, and 3) people from other race/gender/sexual orientation groups | 6 Months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |